119 related articles for article (PubMed ID: 2941223)
1. Allergic contact sensitivity to chlorphenesin.
Burns DA
Contact Dermatitis; 1986 Apr; 14(4):246. PubMed ID: 2941223
[No Abstract] [Full Text] [Related]
2. Chlorphenesin sensitivity.
Brown R
Contact Dermatitis; 1981 May; 7(3):162. PubMed ID: 6456118
[No Abstract] [Full Text] [Related]
3. Sensitivity to topical medicaments among suspected cases of footwear dermatitis.
Saha M; Srinivas CR; Shenoi SD; Balachandran C; Acharya S
Contact Dermatitis; 1993 Jan; 28(1):44-5. PubMed ID: 8428453
[No Abstract] [Full Text] [Related]
4. Fixed drug eruption from chlorphenesin carbamate.
Coskey RJ
JAMA; 1982 Jul; 248(1):30-1. PubMed ID: 6211558
[No Abstract] [Full Text] [Related]
5. Allergic contact dermatitis from tioconazole without cross-sensitivity to other imidazoles.
Gibson G; Buckley A; Murphy GM
Contact Dermatitis; 1994 May; 30(5):308. PubMed ID: 8088154
[No Abstract] [Full Text] [Related]
6. Contact allergy to chlorphenesin.
Dyring-Andersen B; Elberling J; Duus Johansen J; Zachariae C
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1019. PubMed ID: 24628968
[No Abstract] [Full Text] [Related]
7. Allergic contact dermatitis from prilocaine, one of the local anaesthetics in EMLA cream.
van den Hove J; Decroix J; Tennstedt D; Lachapelle JM
Contact Dermatitis; 1994 Apr; 30(4):239. PubMed ID: 8033552
[No Abstract] [Full Text] [Related]
8. Two cases of facial dermatitis due to chlorphenesin in cosmetics.
Brown VL; Orton DI
Contact Dermatitis; 2005 Jan; 52(1):48-9. PubMed ID: 15701134
[No Abstract] [Full Text] [Related]
9. Cancer chemotherapy and skin changes.
Vogelzang NJ; Ratain MJ
Ann Intern Med; 1985 Aug; 103(2):303-4. PubMed ID: 3160276
[No Abstract] [Full Text] [Related]
10. Diagnosis in oncology. Hand-foot syndrome.
Jucgla A; Sais G
J Clin Oncol; 1997 Sep; 15(9):3164. PubMed ID: 9312563
[No Abstract] [Full Text] [Related]
11. Toxic skin reaction restricted to palms and soles after high-dose methotrexate.
Martins da Cunha AC; Rappersberger K; Gadner H
Pediatr Hematol Oncol; 1991; 8(3):277-80. PubMed ID: 1835883
[No Abstract] [Full Text] [Related]
12. Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
Tamayo-Orbegozo E; Iruin-Sanz A; Oñate-Muzás E; Segrelles-Bellmunt G
Farm Hosp; 2011; 35(1):46-7. PubMed ID: 20619714
[No Abstract] [Full Text] [Related]
13. Sunitinib-induced hand-foot syndrome: a new, distinct form.
Fife DJ; Wu JJ; Behnam SE; Linden KG
Clin Exp Dermatol; 2010 Mar; 35(2):200-1. PubMed ID: 19486049
[No Abstract] [Full Text] [Related]
14. [Dermatologic toxicity to sorafenib].
Velázquez D; de la Cueva P; Zamberk P; Lázaro P
Actas Dermosifiliogr; 2009; 100(6):518-20. PubMed ID: 19709563
[No Abstract] [Full Text] [Related]
15. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur.
Jucglà A; Sais G; Navarro M; Peyri J
Arch Dermatol; 1995 Mar; 131(3):364-5. PubMed ID: 7887678
[No Abstract] [Full Text] [Related]
16. Anthracycline-induced toxicity affecting palmar and plantar skin.
Jones AP; Crawford SM
Br J Cancer; 1989 May; 59(5):814. PubMed ID: 2525400
[No Abstract] [Full Text] [Related]
17. Mesalazine-induced bullous fixed drug eruption.
Salman A; Seckin Gencosmanoglu D; Alahdab YO; Giménez-Arnau AM
Contact Dermatitis; 2018 Jul; 79(1):34-35. PubMed ID: 29446099
[No Abstract] [Full Text] [Related]
18. Hand-foot syndrome.
Pike K
Oncol Nurs Forum; 2001; 28(10):1519-20. PubMed ID: 11759299
[No Abstract] [Full Text] [Related]
19. [Palmoplantar cutaneous reaction to sorafenib].
Echeverría B; Llombart B; Botella-Estrada R; Guillén C
Actas Dermosifiliogr; 2009 Oct; 100(8):736-7. PubMed ID: 19775561
[No Abstract] [Full Text] [Related]
20. Purple toe syndrome.
Akle CA; Joiner CL
J R Soc Med; 1981 Mar; 74(3):219. PubMed ID: 6451698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
